The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Acceleron Pharma Inc. | COM | 00434H108 | 14,357 | 250,863 | SH | SOLE | 250,863 | 0 | 0 | ||
Achaogen, Inc. | COM | 004449104 | 9,474 | 2,374,418 | SH | SOLE | 2,374,418 | 0 | 0 | ||
Aclaris Therapeutics, Inc. | COM | 00461U105 | 4,536 | 312,368 | SH | SOLE | 312,368 | 0 | 0 | ||
Aerie Pharmaceuticals, Inc. | COM | 00771V108 | 105,130 | 1,708,046 | SH | SOLE | 1,708,046 | 0 | 0 | ||
Aimmune Therapeutics, Inc. | COM | 00900T107 | 21,858 | 801,240 | SH | SOLE | 801,240 | 0 | 0 | ||
Alder BioPharmaceuticals, Inc. | COM | 014339105 | 48,986 | 2,942,130 | SH | SOLE | 2,942,130 | 0 | 0 | ||
Arcus Biosciences, Inc. | COM | 03969F109 | 48,030 | 3,445,461 | SH | SOLE | 3,445,461 | 0 | 0 | ||
Ardelyx Inc. | COM | 039697107 | 567 | 130,304 | SH | SOLE | 130,304 | 0 | 0 | ||
Ascendis Pharma A/S | SPONSORED ADR | 04351P101 | 13,576 | 191,588 | SH | SOLE | 191,588 | 0 | 0 | ||
Audentes Therapeutics, Inc. | COM | 05070R104 | 12,484 | 315,331 | SH | SOLE | 315,331 | 0 | 0 | ||
BioDelivery Sciences International, Inc. | COM | 09060J106 | 1,763 | 629,656 | SH | SOLE | 629,656 | 0 | 0 | ||
Biohaven Pharmaceutical Holding Company Ltd. | COM | G11196105 | 3,969 | 105,706 | SH | SOLE | 105,706 | 0 | 0 | ||
Blueprint Medicines Corporation | COM | 09627Y109 | 15,612 | 200,000 | SH | SOLE | 200,000 | 0 | 0 | ||
CymaBay Therapeutics, Inc. | COM | 23257D103 | 17,307 | 1,562,040 | SH | SOLE | 1,562,040 | 0 | 0 | ||
Epizyme, Inc. | COM | 29428V104 | 9,728 | 917,715 | SH | SOLE | 917,715 | 0 | 0 | ||
Immunomedics, Inc. | COM | 452907108 | 56,069 | 2,691,729 | SH | SOLE | 2,691,729 | 0 | 0 | ||
Myokardia, Inc. | COM | 62857M105 | 24,274 | 372,300 | SH | SOLE | 372,300 | 0 | 0 | ||
Pacific Biosciences of California, Inc. | COM | 69404D108 | 6,140 | 1,135,000 | SH | SOLE | 1,135,000 | 0 | 0 | ||
Replimune Group, Inc. | COM | 76029N106 | 12,552 | 779,656 | SH | SOLE | 779,656 | 0 | 0 | ||
Sangamo Therapeutics, Inc. | COM | 800677106 | 4,502 | 265,605 | SH | SOLE | 265,605 | 0 | 0 | ||
Solid Biosciences Inc. | COM | 83422E105 | 11,223 | 237,884 | SH | SOLE | 237,884 | 0 | 0 | ||
Tocagen, Inc. | COM | 888846102 | 2,316 | 148,552 | SH | SOLE | 148,552 | 0 | 0 | ||
Verona Pharma Plc | SPONSORED ADS | 925050106 | 6,266 | 500,883 | SH | SOLE | 500,883 | 0 | 0 | ||
WAVE Life Sciences Ltd. | SHS | Y95308105 | 2,500 | 50,000 | SH | SOLE | 50,000 | 0 | 0 |